Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
Experimental evidence shows cross-talk in mammary cells between estrogen, insulin-like growth factor I (IGF-I) and their respective receptors and possible synergistic effects of estrogen receptor (ER) activation and increased IGF-I signaling with regard to breast tumor development, and epidemiologic...
Autors principals: | Kaaks, R, Johnson, T, Tikk, K, Sookthai, D, Tjønneland, A, Roswall, N, Overvad, K, Clavel-Chapelon, F, Boutron-Ruault, M, Dossus, L, Rinaldi, S, Romieu, I, Boeing, H, Schütze, M, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Palli, D, Grioni, S, Tumino, R, Sacerdote, C, Panico, S, Buckland, G, Argüelles, M, Sánchez, M |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2014
|
Ítems similars
-
Insulin-like growth factor i and risk of breast cancer by age and hormone receptor status - A prospective study within the EPIC cohort
per: Kaaks, R, et al.
Publicat: (2014) -
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
per: Kaaks, R, et al.
Publicat: (2014) -
Prolactin determinants in healthy women: A large cross-sectional study within the EPIC cohort.
per: Tikk, K, et al.
Publicat: (2014) -
Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
per: Tikk, K, et al.
Publicat: (2014) -
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
per: James, R, et al.
Publicat: (2011)